BP do deals and takeovers at any time, from pre clinical to post phase 3.
Whilst cf33 is in a Phase 1, it's a Phase 1 where efficacy is indicated too. So it's like a Phase 2.
Many Phase 1 trials test just safety on health volunteers.
The perfect safety profile means that only mild efficacy is enough for these hard to treat cancers to get approved and be commercial.
But I think we will see major efficacy.
Interesting times ahead.
Media Thread, page-12310
-
- There are more pages in this discussion • 2,720 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
